|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|NIH Registration Number:||0082|
|NIH Approval Number:||NIHhESC-10-0082|
|Available for Distribution:||Yes|
Whitehead Insitute may require documentation of acceptable ESCRO review (or equivalent) for the research planned with the line.
|NIH Restrictions:||(No Additional Restrictions)|
WIBR4, 5, and 6 lines were derived under 5% O2 and were split in half at the first passage immediately after stable establishment of hESCs, with one half remaining at 5% O2 (WIBR4/5/6 5%) and the other half shifted to culture under 20% O2 (WIBR4/5/6 20%). The oxygen concentration under which the line was maintained after the first splitting may be indicated with a superscript. Please see Lengner CJ et al. (2010) Derivation of pre-x inactivation human embryonic stem cell line in physiological oxygen conditions. Cell. 141(5):872-83 for further information.
|Submitting Organization:||Whitehead Institute for Biomedical Research|
|Provider Name:||Whitehead Institute for Biomedical Research/Maya Mitalipova|
(Emails that are offensive or unrelated to stem cells will be deleted.)